loader image

Pharma’s gene and cell therapy ambitions will kick into high gear in 2020—despite some major hurdles

There are at least 800 gene therapies in the biopharma pipeline, according to the FDA. (Photo by kirstypargeter/iStock/Getty Images Plus/Getty Images)
avatar